YAP1 and cancer: To assess whether the inhibitor of YAP1/TEAD interaction verteporfin can affect HER2-positive cancer-cell growth and proliferation, we performed a pharmacological assay to evaluate its effects on both sensitive and trastuzumab-resistant cell lines (Figure S6).